Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Indolinones disrupt the function of wild-type and mutant Kit

Sep. 26, 2002

ODAC votes for accelerated approval of Iressa

Sep. 26, 2002

Cytokinetics describes preparation and use of mitotic kinesin KSP inhibitors

Sep. 26, 2002

Tarceva receives second fast track designation

Sep. 25, 2002

FDA issues approvable letter for Metvix

Sep. 25, 2002

Worldwide development and marketing agreement for epothilone D in cancer

Sep. 25, 2002

New product for cancer heading for clinical testing at ProMetic

Sep. 25, 2002

Novel VEGFR inhibitors prepared and tested at Taisho

Sep. 25, 2002

GSK designs new series of antiangiogenic agents

Sep. 23, 2002

Hybridon and Aegera collaborate to develop antisense drug targeting XIAP gene

Sep. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...